Continuously provide innovative solutions to clinical and health difficulties or pain points
More
Continuously provide innovative solutions to clinical and health difficulties or pain points
Two-wheel drive with technological innovation and clinical value
Adhering to the dual drive of "technical innovation" and "clinical value", with the R&D and industrialization of "new markers/underlying technologies/key raw materials/automatic instruments" as the core, it is committed to treating malignant tumors, neurodegenerative diseases and major infectious diseases STD diagnosis offers innovative solutions!
Internationally leading, complete categories, covering the whole process of tumor diagnosis
The main product lines include molecular (PCR, NGS), protein (Elisa, chemiluminescence, POCT), exosome (mRNA, miRNA and protein)
Self-made key materials
High affinity recombinant antibodies, humanized or bispecific antibodies, eukaryotic antigens, traceable reference materials, engineered exosome standards, CTC standards, library building reagents, UMI linkers, key reaction enzymes, specific magnetic beads, Modified fillers, etc.
—— There is no "stuck neck" problem of raw materials suitable for industrialization, uncontrollable quality, high cost, long supply cycle and single source.
Talent is the core asset of Microdiag
Eclectic selection, employment and retention
Talent-oriented, focus on wisdom, inspire innovation, and dare to excel
Advance into the United States, realize the dual reporting of core products in China and the United States, and firmly practice "the world is true"
In 5 years, Microdiag entered the first-tier market in the United States and obtained original international recognition and interest premium.
Continuously provide innovative solutions to clinical and health difficulties or pain points
More
Product development for early detection and detection in the fields of cancer, neurodegenerative diseases, and infectious diseases
Focus on the creation of immune and molecular POCT production lines
Dedicated to breakthroughs in HPV self testing and AD blood screening products
More
Self-developed ctDNA liquid biopsy and unique tumor marker detection reagents and other tumor prevention and rehabilitation detection technologies are the core
A "refined" tool for postoperative follow-up management/self-management of bowel cancer patients
Can carry out common medical laboratory subjects including clinical cytomolecular genetics, clinical immunity, serological testing and other majors, mainly engaged in tumor genetic testing, testing services related to major infectious diseases
4月22日下午，国家商务部外(wai)贸司(si)刘长于(yu)巡(xun)视(shi)员一(yi)行(xing)莅临上海(hai)良润生物(wu)医(yi)(yi)药(yao)科技有限公司(si)开展关于(yu)医(yi)(yi)疗物(wu)资(zi)出口(kou)的调查研究，此次调研旨在(zai)了(le)解企(qi)业(ye)医(yi)(yi)疗物(wu)资(zi)生产(chan)及出口(kou)基本情况(kuang)(kuang)、企(qi)业(ye)医(yi)(yi)疗物(wu)资(zi)质量管控的工(gong)作情况(kuang)(kuang)，以及存在(zai)的问(wen)题和(he)
根据上海(hai)市(shi)委书(shu)记李强11月17日(ri)在(zai)浦东调研专题座谈会的(de)指示(shi)精神，按照祖亮书(shu)记的(de)指示(shi)要求，为谋划推(tui)动(dong)长三角自(zi)(zi)贸试验(yan)区(qu)(qu)(qu)联动(dong)发展(zhan)，上海(hai)浦东新(xin)区(qu)(qu)(qu)杨朝副区(qu)(qu)(qu)长于12月23日(ri)上午在(zai)浦东新(xin)区(qu)(qu)(qu)管委会主持召开了长三角自(zi)(zi)贸试验(yan)区(qu)(qu)(qu)企业座谈
着国家对“精准医疗”战(zhan)略规划的(de)(de)(de)(de)(de)启动(dong)，基(ji)于大数据的(de)(de)(de)(de)(de)精准分析，运用分子诊(zhen)断的(de)(de)(de)(de)(de)技术的(de)(de)(de)(de)(de)个(ge)体化的(de)(de)(de)(de)(de)筛查(cha)路径成(cheng)为(wei)战(zhan)略发展的(de)(de)(de)(de)(de)方(fang)向(xiang)和重中之重。
To Provide Innovative Solutions for
the Diagnosis of Critical Diseases
Seeking Truth from Facts
Pioneering on Our Innovation
To Be a Leading IVD Enterprise Driven by Liquid
Biopsy Technologies and Targeting International Markets
Simplicity Integrity Excellence
Hotline: 0512-8187-9848
Address: Building 16, Northwest District, Suzhou Nano City, No. 99, Jinji Lake Avenue, Suzhou Industrial Park, Jiangsu Province
Microdiag
Great Health
